CIC
AGN.PRA

Chilton Investment Company’s Allergan plc AGN.PRA Stock Holding History

Chilton Investment Company’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,350
Closed -$3.95M – 141
2017
Q3 		$3.95M Hold
5,350
– – 0.15% 64
2017
Q2 		$4.64M Hold
5,350
– – 0.18% 65
2017
Q1 		$4.54M Sell
5,350
-37,556
-88% -$31.1M 0.18% 61
2016
Q4 		$32.7M Sell
42,906
-6,539
-13% -$4.94M 1.33% 29
2016
Q3 		$40.6M Buy
49,445
+1,757
+4% +$1.52M 1.59% 25
2016
Q2 		$39.8M Sell
47,688
-1,474
-3% -$1.23M 1.41% 27
2016
Q1 		$45.2M Buy
49,162
+2,604
+6% +$2.49M 1.66% 25
2015
Q4 		$48M Buy
46,558
+39,584
+568% +$39.8M 1.69% 25
2015
Q3 		$6.58M Buy
6,974
+3,518
+102% +$3.67M 0.23% 55
2015
Q2 		$3.61M Buy
+3,456
New +$3.62M 0.13% 76

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Chilton Investment Company's AGN.PRA Position: Q4 2017 in Review

Chilton Investment Company sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 5,350 shares — an estimated $3.95M sold.

Chilton Investment Company first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $48M in Q4 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Chilton Investment Company reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Chilton Investment Company sold 5,350 Allergan plc shares in Q4 2017, an estimated $3.95M.
  • Chilton Investment Company first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Chilton Investment Company's Allergan plc position peaked at $48M in Q4 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Chilton Investment Company's 13F filing for Q4 2017, filed 7 Feb 2018.